No. |
Product Name |
CAS No. |
Spec |
Price |
|
| A-1521 |
CP 226269 ≥99% |
220941-93-5 |
|
|
| A-1847 |
CP 316819 ≥99% |
186392-43-8 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2216 |
CP 346086 ≥99% |
186390-48-7 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1495 |
CP 466722 ≥99% |
1080622-86-1 |
|
|
| A-2104 |
CP 471474 ≥99% |
210755-45-6 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1662 |
CP 547632 ≥98% |
252003-65-9 |
|
|
| A-1604 |
CP 615003 mesylate ≥99% |
1259477-42-3 |
|
|
| A-1338 |
CP 690550(Tasocitinib;Tofacitinib) ≥99% |
477600-75-2 |
|
|
| A-1537 |
CP 724714 ≥98% |
383432-38-0 |
|
|
| A-2114 |
CP 775146 ≥99% |
702680-17-9 |
|
|
| A-2147 |
CpdD HCl(GhrR antagonist CpdD) ≥99% |
N.A. |
|
|
| A-1165 |
cPEPCK inhibitor ≥98% |
628279-07-2 |
|
|
| A-2125 |
CPI 613 ≥100% |
95809-78-2 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1431 |
CPPHA ≥99% |
693288-97-0 |
|
|
| A-1868 |
CRAC inhibitor 44 ≥99% |
944917-72-0 |
|
|
| A-1415 |
CT 53518(MLN 518;Tandutinib) ≥99% |
387867-13-2 |
|
|
| A-1972 |
CTEP ≥99% |
871362-31-1 |
|
|
| A-1965 |
CX 4945 HCl(Silmitasertib HCl) ≥98% |
1009820-21-6 |
|
|
| A-2173 |
CX 5461 ≥99% |
1138549-36-6 |
|
|
| A-1800 |
CXCR3 Antagonist 6c(Compound 6c) ≥99% |
870998-13-3 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
